XBiotech Inc

XBiotech’s technologies provide us with the unique ability to develop drug candidates for viral or bacterial infectious diseases. Our core discovery technology enables the rapid development of antibody therapies directly from human blood samples that can be used to neutralize infectious disease. Our True Human antibody therapies allow us to recapitulate key components of the natural immunity obtained from an immune blood donor. We combine this discovery program with a novel manufacturing platform to facilitate rapid commercial-scale production. We believe our capabilities are unparalleled in the pharmaceutical industry to discover and create novel, effective treatments for infectious disease, including rapidly addressing infectious disease outbreaks.